Tuning the Affinity of Chimeric Antigen Receptors Enhances the Function of Human Engineered Regulatory T Cells
European Journal of Immunology · 2026-06 · 56 (6)
DOI: 10.1002/eji.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 17.06.2026. Verfasst von Ada Sera Kurt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences (SIMS), King's College London University and King's College Hosp…. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rosetrees Trust, National Institute for Health and Care Research.
Abstract (Originalsprache)
Chimeric antigen receptors (CAR) incorporating single‐chain variable fragments (scFv) exhibit much higher affinity for their cognate antigens than native T cell receptors (TCR). Reducing the affinity of the CAR has been shown to improve the function of effector CAR‐T cells by limiting their activation‐induced exhaustion while preserving their capacity for serial killing of antigen‐rich tumor cells. CAR technologies are increasingly being applied to regulatory T cell (Treg)–based immunotherapies as well. However, the impact of CAR affinity on Treg biology and function remains poorly understood. To address this question, we transduced purified human Tregs with second‐generation CAR constructs bearing scFvs with varying affinities toward HLA‐A2 and compared their properties both in vitro and in vivo. High‐affinity (HA) CAR‐Tregs displayed higher avidity and more pronounced CAR downregulation upon antigen engagement. In contrast, low‐affinity (LA) CAR‐Tregs exhibited enhanced antigen‐specific activation and superior suppressive capacity. These differences were confirmed using human and mouse precision‐cut liver slices and a xenogeneic graft‐versus‐host disease (GVHD) murine model. LA CAR‐Tregs exhibited greater accumulation/persistence, delayed GVHD onset, and improved survival than HA CAR‐Tregs. Our findings, indicating that CAR affinity strongly influences CAR‐Treg function, provide important considerations for the optimization of engineered Treg therapies and the benchmarking of existing cell products.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences (SIMS), King's College London University and King's College Hospital, London, UK.
- Institute of Liver Studies, King's College Hospital, London, UK.
- Quell Therapeutics, London, UK.
ORCID-Profile: Minahil Sharjeel
Förderung
- Rosetrees Trust
- National Institute for Health and Care Research
Zitieren
APA
Kurt, A. S., Elgosbi, M., Kodela, E., Landmann, E., Ruiz, P., Zen, Y., Torres-Yaguana, J., Puttick, A., Bustamante, Q., Sharjeel, M., Murshid, H., Martinez-Llordella, M., & Sanchez-Fueyo, A. (2026). Tuning the Affinity of Chimeric Antigen Receptors Enhances the Function of Human Engineered Regulatory T Cells. European Journal of Immunology, 56(6). https://doi.org/10.1002/eji.70226
Vancouver
Kurt AS, Elgosbi M, Kodela E, Landmann E, Ruiz P, Zen Y, et al. Tuning the Affinity of Chimeric Antigen Receptors Enhances the Function of Human Engineered Regulatory T Cells. European Journal of Immunology. 2026;56(6). doi:10.1002/eji.70226
BibTeX
@article{Kurt2026,
author = {Kurt, Ada Sera and Elgosbi, Marwa and Kodela, Elisavet and Landmann, Emmanuelle and Ruiz, Paula and Zen, Yoh and Torres-Yaguana, Jorge and Puttick, Alexander and Bustamante, Quisha and Sharjeel, Minahil and Murshid, Hannan and Martinez-Llordella, Marc and Sanchez-Fueyo, Alberto},
title = {Tuning the Affinity of Chimeric Antigen Receptors Enhances the Function of Human Engineered Regulatory T Cells},
journal = {European Journal of Immunology},
year = {2026},
volume = {56},
number = {6},
doi = {10.1002/eji.70226}
}
EUVIMED